![Thomas Woiwode](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Woiwode
Presidente presso
VectivBio AG
Profilo
Thomas F.
Woiwode is the founder of Euro Ventures 4, Inc., founded in 2013.
Dr. Woiwode is also the founder of Euro Ventures, Inc. Dr. Woiwode is Chairman at Therachon SAS and VectivBio AG.
Dr. Woiwode is Director at TempestTx, Inc. since 2018.
Dr. Woiwode is Managing Director at Versant Venture Management LLC since 2014.
Dr. Woiwode is Director at Inception Sciences, Inc., Anokion SA, Kanyos Bio, Inc., Inception IBD, Inc., Versant Venture Capital VI (Canada) LP, Jecure Therapeutics, Inc., CODA Biotherapeutics, Inc., Bright Peak Therapeutics AG, Jengu Therapeutics, Inc., Bright Peak Therapeutics, Inc. since 2018, and Santa Ana Bio, Inc. Former positions include Chairman-Supervisory Board at Therachon Holding GmbH; Chairman at VectivBio Holding AG from 2019 to 2023; Managing Director at Versant Corp.; Director at CymaBay Therapeutics, Inc., Antipodean Pharmaceuticals, Inc., Sentient Pharmaceuticals, Inc., Saegis Pharmaceuticals, Inc., Vividion Therapeutics, Inc.; Independent Director at Astellas Gene Therapies, Inc. from 2013 to 2017; Independent Director at Adverum Biotechnologies, Inc. from 2016 to 2021; Independent Non-Executive Director at CRISPR Therapeutics AG from 2014 to 2019; Independent Director at Gritstone bio, Inc. from 2015 to 2021; Independent Non-Executive Director at Passage Bio, Inc. from 2018 to 2023; Independent Director at Aligos Therapeutics, Inc. from 2018 to 2023; Independent Director at Tempest Therapeutics, Inc. from 2019 to 2023; Chief Business Officer at Amira Pharmaceuticals, Inc., Synosia Therapeutics AG, and Flexion Therapeutics, Inc.; Research Scientist at XenoPort, Inc. from 2000 to 2002; Chief Operating Officer at Okarios AG from 2011 to 2013.
Education includes a doctorate from Stanford University conferred in 2000 and an undergraduate degree from the University of California, Berkeley conferred in 1993.
Posizioni attive di Thomas Woiwode
| Società | Posizione | Inizio |
|---|---|---|
Anokion SA
 Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Direttore/Membro del Consiglio | - |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Direttore/Membro del Consiglio | - |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Direttore/Membro del Consiglio | - |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Direttore/Membro del Consiglio | - |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Direttore/Membro del Consiglio | - |
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Functions as a venture capital fund | Direttore/Membro del Consiglio | - |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Direttore/Membro del Consiglio | 28/03/2018 |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Direttore/Membro del Consiglio | - |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Investitore di Private Equity | 01/01/2002 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Thomas Woiwode
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Thomas Woiwode
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
39
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 39 |
|---|---|
Versant Corp.
 Versant Corp. Packaged SoftwareTechnology Services Designs and supports high performance object database management system for commercial applications | Technology Services |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Antipodean Pharmaceuticals, Inc.
 Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides pre clinical services | Health Technology |
Sentient Pharmaceuticals, Inc.
 Sentient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for outpatient interventional procedures | Health Technology |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
Euro Ventures 4, Inc.
 Euro Ventures 4, Inc. Investment ManagersFinance Functions as an private equity fund | Finance |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Saegis Pharmaceuticals, Inc.
 Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Anokion SA
Anokion SA BiotechnologyHealth Technology Operates as a biotechnology company which develops therapies for antigen-specific immune tolerance | Health Technology |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for type 1 diabetes | Health Technology |
Euro Ventures, Inc. | |
Therachon SAS
 Therachon SAS BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Commercial Services |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Versant Venture Capital VI (Canada) LP
Versant Venture Capital VI (Canada) LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Commercial Services |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
Jengu Therapeutics, Inc.
 Jengu Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Okarios AG | |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
